https://www.distalmotion.com/dexter-series-e-90m-to-make-sense-of-robotic-surgery/Image credits: Distalmotion
Distalmotion, a Swiss-based medical device company, received European CE Mark for its surgical robot Dexter. Dexter combines the affordability of laparoscopy with the benefits of robotic surgery. Manufactured in Switzerland, Dexter brings simplicity and versatility in minimally invasive surgical care, making robotics accessible for a wider repertoire of procedures and enabling surgeons
Distalmotion-Chef Michael Friedrich über Anwendungsmöglichkeiten des Roboterarms. Das Unternehmen Distalmotion will mit seinem OP-Roboter Dexter Kliniken in aller Welt erobern - und das Leben der Ärzte einfacher machen. Die Business-Idee Ein operativer Eingriff braucht Präzision, Konzentration und höchste Professionalität. Die Firma Distalmotion will Chirurgen und Chirurginnen das Leben leichter machen und hat dafür einen Roboterarm gebaut, der händische
Distalmotion – Dexter successful validation brings Distalmotion surgical robot one-step closer to commercialization
Dexter validation confirms Distalmotion surgical robot is safe for use and meets surgeons and nurses expectations Around 20 surgeons and 20 nurses from leading European hospitals, across urology, gynaecology and general surgery participated in Dexter validation end of February and early March 2020 Surgical teams successfully performed surgical procedures using Dexter, including
Distalmotion – Dexter wins iF Design Award 2020: A surgical robot from Vaud, on the world design podium
Dexter’s unique approach to robotics has been awarded an iF Design Award. This is a testimony to the ground-breaking, innovative work carried out by our team in close collaboration with our like-minded partner McKinsey Design. Design thinking and an intense journey of hands-on testing and user-driven design iterations led us to arrive at
A major milestone towards Dexter's go-to-market was reached when 40+ surgeons and assistant surgeons participated in a study, tested Dexter, and validated the robot’s core value propositions. Here's the full interview with Prof. David Jayne, recapping his findings from the testing procedure.
Designs are needed to reduce the complexity and cost of robotic surgery. by Michael Friedrich Is widespread adoption of surgical robots around the corner? The question is certainly timely given the recent developments in the sector. To name a few, in mid-September, CMR announced it raised $243 million in a Series C
Roger Smith, PhD of AdventHealth Nicholson Center sits down with Michael Friedrich, CEO Distalmotion, to discuss their new technology Dexter, and how it fits into the robotic surgery landscape.
Distalmotion has successfully completed a cadaver study involving Dexter, its surgical robot. The 40+ surgeons and nurses who participated in the study, and tested the robot for surgical procedures, validated Dexter core value proposition of removing complexity out of robotic surgery. Distalmotion aims to remove the complexity out of robotic surgery to fast track
With Dexter, the robot of the Swiss start-up Distalmotion, hospitals can reduce the costs for surgeries by more than 90% compared to traditional robotic solutions. Distalmotion has now signed a first distribution agreement for Dexter. Today’s surgical robots have their roots in remote surgery for the military. They were designed to allow surgeries even